89bio Inc (ETNB) common stock has been delisted pending stock liquidation, as noted by Robinhood’s corporate actions tracker. This development impacts US investors holding shares in the clinical-stage biotech.
89bio Inc, a clinical-stage biopharmaceutical company, saw its common stock (ETNB) delisted pending a stock liquidation process. The update appears in Robinhood’s corporate actions tracker, signaling potential closure for shareholders. Details on the liquidation remain pending as of the latest available information.
The stock traded on Nasdaq under the ticker ETNB prior to delisting. 89bio focused on developing therapies for liver diseases, including non-alcoholic steatohepatitis (NASH). This event follows typical paths for…